lilly tirzepatide approval https://investor.lilly.com/news-releases/news-release-details/zepbound- tirzepatide-most-prescribed-weight-management “Eli and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound Eli Lilly Adds Highest Doses

Nakazato M, Murakami N, Date Y, et al

This is speculation based on the broader GLP-1 nasal delivery literature, not confirmed data for retatrutide specifically

For people taking GLP-1s like Zepbound, however, its especially important to take up resistance training, Dr

Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (step 2): a randomized, double-blind, double-dummy, placebo-controlled, phase 3 trial

Read more Insurance covers Mounjaro only for diabetes for weight loss, here's a path that skips insurance BCBS of Minnesota covers Mounjaro for diabetes only even where MN Medicaid covers weight-loss GLP-1s, that applies to Zepbound and Wegovy, not Mounjaro

If its more than 12 hours since your scheduled injection time, skip that dose and continue from the following day